Picard Medical Inc (PMI) is not a good buy for a beginner investor with a long-term strategy. The stock is currently facing significant legal challenges, poor technical indicators, and weak financial performance. Given the lack of positive catalysts and substantial risks, it is advisable to avoid investing in this stock at this time.

Technical Analysis

The stock is in a bearish trend with MACD below 0 and negatively contracting, RSI at 16.869 indicating oversold conditions, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The key support level is at 1.128, with resistance at 2.175.

Positive Catalysts

No significant positive catalysts identified.

Neutral/Negative Catalysts

The company is facing multiple class action lawsuits for securities fraud and misleading statements, with allegations of a fraudulent promotion scheme. The stock also experienced a significant 70% drop in October 2025, leading to major investor losses.

Financial Performance

In Q3 2025, revenue increased by 34.73% YoY to $1,187,000, but the company remains unprofitable with a net loss of $10,426,000 (up 51.34% YoY). EPS improved to -0.14 (up 40% YoY), but gross margin dropped significantly to -10.95%, down 85.67% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast PMI stock price to rise

Buy

Hold

Sell

Current: 1.080

Low

Averages

High